MINARIKOVA, Petra, Lucie BENESOVA, Tereza HALKOVA, Barbora BELSANOVA, Inna TUCKOVA, Frantisek BELINA, Ladislav DUŠEK, Miroslav ZAVORAL a Marek MINARIK. Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers. Gastroenterology Research and Practice. New York: Hindawi Publishing Corporation, 2016, roč. 2016, č. 9408190, s. 1-8. ISSN 1687-6121. Dostupné z: https://dx.doi.org/10.1155/2016/9408190.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers
Autoři MINARIKOVA, Petra (203 Česká republika), Lucie BENESOVA (203 Česká republika), Tereza HALKOVA (203 Česká republika), Barbora BELSANOVA (203 Česká republika), Inna TUCKOVA (203 Česká republika), Frantisek BELINA (203 Česká republika), Ladislav DUŠEK (203 Česká republika, garant, domácí), Miroslav ZAVORAL (203 Česká republika) a Marek MINARIK (203 Česká republika).
Vydání Gastroenterology Research and Practice, New York, Hindawi Publishing Corporation, 2016, 1687-6121.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30200 3.2 Clinical medicine
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 1.863
Kód RIV RIV/00216224:14110/16:00092162
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1155/2016/9408190
UT WoS 000385749600001
Klíčová slova anglicky HELICOBACTER-PYLORI INFECTION; IN-SITU HYBRIDIZATION; PROBE AMPLIFICATION; THERAPEUTIC TARGET; GENE AMPLIFICATION; CYTOPLASMIC P27; BREAST-CANCER; DIFFUSE-TYPE; HER2 STATUS; CARCINOMA
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Ing. Mgr. Věra Pospíšilíková, učo 9005. Změněno: 6. 12. 2016 11:18.
Anotace
Background. Gastric cancer is known for a notable variety in the course of the disease. Clinical factors, such as tumor stage, grade, and localization, are key in patient survival. It is expected that molecular factors such as somatic mutations and gene amplifications are also underlying tumor biological behavior and may serve as factors for prognosis estimation. Aim. The purpose of this study was to examine gene amplifications from a panel of genes to uncover potential prognostic marker candidates. Methods. A panel of gene amplifications including 71 genes was tested by multiplex ligation-dependent probe amplification (MLPA) technique in 76 gastric cancer samples from a Caucasian population. The correlation of gene amplification status with patient survival was determined by the Kaplan-Meier method. Results. The amplification of two cell cycle regulators, CCND1 and CDKN1B, was identified to have a negative prognostic role. The medial survival of patients with gastric cancer displaying amplification compared to patients without amplification was 192 versus 725 days for CCND1 (P = 0.0012) and 165 versus 611 days for CDKN1B (P = 0.0098). Conclusion. Gene amplifications of CCND1 and CDKN1B are potential candidates to serve as prognostic markers for the stratification of patients based on the estimate of survival in the management of gastric cancer patients.
VytisknoutZobrazeno: 26. 4. 2024 17:16